Report Detail

Pharma & Healthcare Global Soft Capsules Drugs Market Size, Status and Forecast 2021-2027

  • RnM4284620
  • |
  • 08 February, 2021
  • |
  • Global
  • |
  • 131 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Liquid Core Drugs
    • 1.2.3 Semi-solid Core Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Soft Capsules Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Soft Capsules Drugs Market Perspective (2016-2027)
  • 2.2 Soft Capsules Drugs Growth Trends by Regions
    • 2.2.1 Soft Capsules Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Soft Capsules Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Soft Capsules Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Soft Capsules Drugs Industry Dynamic
    • 2.3.1 Soft Capsules Drugs Market Trends
    • 2.3.2 Soft Capsules Drugs Market Drivers
    • 2.3.3 Soft Capsules Drugs Market Challenges
    • 2.3.4 Soft Capsules Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Soft Capsules Drugs Players by Revenue
    • 3.1.1 Global Top Soft Capsules Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Soft Capsules Drugs Revenue
  • 3.4 Global Soft Capsules Drugs Market Concentration Ratio
    • 3.4.1 Global Soft Capsules Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs Revenue in 2020
  • 3.5 Soft Capsules Drugs Key Players Head office and Area Served
  • 3.6 Key Players Soft Capsules Drugs Product Solution and Service
  • 3.7 Date of Enter into Soft Capsules Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Soft Capsules Drugs Breakdown Data by Type

  • 4.1 Global Soft Capsules Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Soft Capsules Drugs Forecasted Market Size by Type (2022-2027)

5 Soft Capsules Drugs Breakdown Data by Application

  • 5.1 Global Soft Capsules Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Soft Capsules Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Soft Capsules Drugs Market Size (2016-2027)
  • 6.2 North America Soft Capsules Drugs Market Size by Type
    • 6.2.1 North America Soft Capsules Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Soft Capsules Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Soft Capsules Drugs Market Size by Type (2016-2027)
  • 6.3 North America Soft Capsules Drugs Market Size by Application
    • 6.3.1 North America Soft Capsules Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Soft Capsules Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Soft Capsules Drugs Market Size by Application (2016-2027)
  • 6.4 North America Soft Capsules Drugs Market Size by Country
    • 6.4.1 North America Soft Capsules Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Soft Capsules Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Soft Capsules Drugs Market Size (2016-2027)
  • 7.2 Europe Soft Capsules Drugs Market Size by Type
    • 7.2.1 Europe Soft Capsules Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Soft Capsules Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Soft Capsules Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Soft Capsules Drugs Market Size by Application
    • 7.3.1 Europe Soft Capsules Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Soft Capsules Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Soft Capsules Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Soft Capsules Drugs Market Size by Country
    • 7.4.1 Europe Soft Capsules Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Soft Capsules Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Soft Capsules Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Soft Capsules Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Soft Capsules Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Soft Capsules Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Soft Capsules Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Soft Capsules Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Soft Capsules Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Soft Capsules Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Soft Capsules Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Soft Capsules Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Soft Capsules Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Soft Capsules Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Soft Capsules Drugs Market Size (2016-2027)
  • 9.2 Latin America Soft Capsules Drugs Market Size by Type
    • 9.2.1 Latin America Soft Capsules Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Soft Capsules Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Soft Capsules Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Soft Capsules Drugs Market Size by Application
    • 9.3.1 Latin America Soft Capsules Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Soft Capsules Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Soft Capsules Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Soft Capsules Drugs Market Size by Country
    • 9.4.1 Latin America Soft Capsules Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Soft Capsules Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Soft Capsules Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Soft Capsules Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Soft Capsules Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Soft Capsules Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Soft Capsules Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Soft Capsules Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Soft Capsules Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Soft Capsules Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Soft Capsules Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Soft Capsules Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Soft Capsules Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Soft Capsules Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Details
    • 11.1.2 GSK Business Overview
    • 11.1.3 GSK Soft Capsules Drugs Introduction
    • 11.1.4 GSK Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.1.5 GSK Recent Development
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Details
    • 11.2.2 AstraZeneca Business Overview
    • 11.2.3 AstraZeneca Soft Capsules Drugs Introduction
    • 11.2.4 AstraZeneca Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.2.5 AstraZeneca Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Soft Capsules Drugs Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 Vertex
    • 11.4.1 Vertex Company Details
    • 11.4.2 Vertex Business Overview
    • 11.4.3 Vertex Soft Capsules Drugs Introduction
    • 11.4.4 Vertex Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.4.5 Vertex Recent Development
  • 11.5 Roche
    • 11.5.1 Roche Company Details
    • 11.5.2 Roche Business Overview
    • 11.5.3 Roche Soft Capsules Drugs Introduction
    • 11.5.4 Roche Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.5.5 Roche Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Soft Capsules Drugs Introduction
    • 11.6.4 Novartis Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.6.5 Novartis Recent Development
  • 11.7 Teva
    • 11.7.1 Teva Company Details
    • 11.7.2 Teva Business Overview
    • 11.7.3 Teva Soft Capsules Drugs Introduction
    • 11.7.4 Teva Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.7.5 Teva Recent Development
  • 11.8 Chiesi
    • 11.8.1 Chiesi Company Details
    • 11.8.2 Chiesi Business Overview
    • 11.8.3 Chiesi Soft Capsules Drugs Introduction
    • 11.8.4 Chiesi Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.8.5 Chiesi Recent Development
  • 11.9 Sumitomo Dainippon
    • 11.9.1 Sumitomo Dainippon Company Details
    • 11.9.2 Sumitomo Dainippon Business Overview
    • 11.9.3 Sumitomo Dainippon Soft Capsules Drugs Introduction
    • 11.9.4 Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.9.5 Sumitomo Dainippon Recent Development
  • 11.10 Merck
    • 11.10.1 Merck Company Details
    • 11.10.2 Merck Business Overview
    • 11.10.3 Merck Soft Capsules Drugs Introduction
    • 11.10.4 Merck Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.10.5 Merck Recent Development
  • 11.11 Atrium Innovations
    • 11.11.1 Atrium Innovations Company Details
    • 11.11.2 Atrium Innovations Business Overview
    • 11.11.3 Atrium Innovations Soft Capsules Drugs Introduction
    • 11.11.4 Atrium Innovations Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.11.5 Atrium Innovations Recent Development
  • 11.12 Abbott
    • 11.12.1 Abbott Company Details
    • 11.12.2 Abbott Business Overview
    • 11.12.3 Abbott Soft Capsules Drugs Introduction
    • 11.12.4 Abbott Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.12.5 Abbott Recent Development
  • 11.13 Blackmores
    • 11.13.1 Blackmores Company Details
    • 11.13.2 Blackmores Business Overview
    • 11.13.3 Blackmores Soft Capsules Drugs Introduction
    • 11.13.4 Blackmores Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.13.5 Blackmores Recent Development
  • 11.14 The Clorox Company
    • 11.14.1 The Clorox Company Company Details
    • 11.14.2 The Clorox Company Business Overview
    • 11.14.3 The Clorox Company Soft Capsules Drugs Introduction
    • 11.14.4 The Clorox Company Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.14.5 The Clorox Company Recent Development
  • 11.15 Nature Made
    • 11.15.1 Nature Made Company Details
    • 11.15.2 Nature Made Business Overview
    • 11.15.3 Nature Made Soft Capsules Drugs Introduction
    • 11.15.4 Nature Made Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.15.5 Nature Made Recent Development
  • 11.16 By-health
    • 11.16.1 By-health Company Details
    • 11.16.2 By-health Business Overview
    • 11.16.3 By-health Soft Capsules Drugs Introduction
    • 11.16.4 By-health Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.16.5 By-health Recent Development
  • 11.17 A&Z Pharmaceutical
    • 11.17.1 A&Z Pharmaceutical Company Details
    • 11.17.2 A&Z Pharmaceutical Business Overview
    • 11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Introduction
    • 11.17.4 A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2016-2021)
    • 11.17.5 A&Z Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Soft Capsules Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Soft Capsules Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Liquid Core Drugs
    Semi-solid Core Drugs

    Segment by Application
    Hospital Pharmacy
    Retail Pharmacy

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    GSK
    AstraZeneca
    Boehringer Ingelheim
    Vertex
    Roche
    Novartis
    Teva
    Chiesi
    Sumitomo Dainippon
    Vertex
    Roche
    Abbott
    Blackmores
    The Clorox Company
    Nature Made
    By-health


    Summary:
    Get latest Market Research Reports on Soft Capsules Drugs. Industry analysis & Market Report on Soft Capsules Drugs is a syndicated market report, published as Global Soft Capsules Drugs Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Soft Capsules Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,813.28
    4,219.92
    5,626.56
    3,260.93
    4,891.40
    6,521.87
    421,968.30
    632,952.45
    843,936.60
    284,952.72
    427,429.08
    569,905.44
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report